From: Screening of selective histone deacetylase inhibitors by proteochemometric modeling
Model | R2 | Q2test | Model | R2 | Q2test |
---|---|---|---|---|---|
Group 1 | Â | Â | Group 2 | Â | Â |
P0-DLI | 0.9616 | 0.7292 | P0-GD-C | 0.9916 | 0.6759 |
P1-DLI | 0.9619 | 0.7427 | P1-GD-C | 0.9909 | 0.7191 |
P2-DLI | 0.9614 | 0.7272 | P2-GD-C | 0.9917 | 0.6215 |
Group 3 | Â | Â | Group 4 | Â | Â |
P0-GD | 0.9895 | 0.7331 | C(P0,DLI) | 0.9860 | 0.6941 |
P1-GD | 0.9897 | 0.7542 | C(P1,DLI) | 0.9811 | 0.7227 |
P2-GD | 0.9894 | 0.7268 | C(P2,DLI) | 0.9898 | 0.6067 |
Group 5 | Â | Â | Group 6 | Â | Â |
P0-DLI-C | 0.9871 | 0.6944 | C(P0,GD) | 0.9914 | 0.6772 |
P1-DLI-C | 0.9846 | 0.7251 | C(P1,GD) | 0.9904 | 0.7190 |
P2-DLI-C | 0.9883 | 0.6519 | C(P2,GD) | 0.9941 | 0.5597 |